MicroRNAs as an emerging target for melanoma therapy

Byungwoo Ryu, Soonyean Hwang, Rhoda M. Alani

Research output: Contribution to journalArticle

Abstract

Despite the growing focus on microRNAs (miRNAs) as novel diagnostic tools and therapeutic targets in cancer, global characterization of miRNA expression patterns and their specific targets in melanoma has lagged. In this issue, Reuland et al. (2012) identify miR-26a as being specifically downregulated in human melanoma cells. They further establish Silencer of Death Domains as a novel target for miR-26a, which functionally mediates melanoma cell death. These findings suggest that miR-26a may serve as a promising novel therapy for subsets of melanoma.

Original languageEnglish (US)
Pages (from-to)1137-1139
Number of pages3
JournalJournal of Investigative Dermatology
Volume133
Issue number5
DOIs
StatePublished - May 2013
Externally publishedYes

Fingerprint

MicroRNAs
Melanoma
Cell death
Therapeutics
Cell Death
Down-Regulation
Neoplasms

ASJC Scopus subject areas

  • Dermatology
  • Biochemistry
  • Cell Biology
  • Molecular Biology

Cite this

MicroRNAs as an emerging target for melanoma therapy. / Ryu, Byungwoo; Hwang, Soonyean; Alani, Rhoda M.

In: Journal of Investigative Dermatology, Vol. 133, No. 5, 05.2013, p. 1137-1139.

Research output: Contribution to journalArticle

Ryu, Byungwoo ; Hwang, Soonyean ; Alani, Rhoda M. / MicroRNAs as an emerging target for melanoma therapy. In: Journal of Investigative Dermatology. 2013 ; Vol. 133, No. 5. pp. 1137-1139.
@article{310f60a18ae24333a975a5fd1afe5792,
title = "MicroRNAs as an emerging target for melanoma therapy",
abstract = "Despite the growing focus on microRNAs (miRNAs) as novel diagnostic tools and therapeutic targets in cancer, global characterization of miRNA expression patterns and their specific targets in melanoma has lagged. In this issue, Reuland et al. (2012) identify miR-26a as being specifically downregulated in human melanoma cells. They further establish Silencer of Death Domains as a novel target for miR-26a, which functionally mediates melanoma cell death. These findings suggest that miR-26a may serve as a promising novel therapy for subsets of melanoma.",
author = "Byungwoo Ryu and Soonyean Hwang and Alani, {Rhoda M.}",
year = "2013",
month = "5",
doi = "10.1038/jid.2012.505",
language = "English (US)",
volume = "133",
pages = "1137--1139",
journal = "Journal of Investigative Dermatology",
issn = "0022-202X",
publisher = "Nature Publishing Group",
number = "5",

}

TY - JOUR

T1 - MicroRNAs as an emerging target for melanoma therapy

AU - Ryu, Byungwoo

AU - Hwang, Soonyean

AU - Alani, Rhoda M.

PY - 2013/5

Y1 - 2013/5

N2 - Despite the growing focus on microRNAs (miRNAs) as novel diagnostic tools and therapeutic targets in cancer, global characterization of miRNA expression patterns and their specific targets in melanoma has lagged. In this issue, Reuland et al. (2012) identify miR-26a as being specifically downregulated in human melanoma cells. They further establish Silencer of Death Domains as a novel target for miR-26a, which functionally mediates melanoma cell death. These findings suggest that miR-26a may serve as a promising novel therapy for subsets of melanoma.

AB - Despite the growing focus on microRNAs (miRNAs) as novel diagnostic tools and therapeutic targets in cancer, global characterization of miRNA expression patterns and their specific targets in melanoma has lagged. In this issue, Reuland et al. (2012) identify miR-26a as being specifically downregulated in human melanoma cells. They further establish Silencer of Death Domains as a novel target for miR-26a, which functionally mediates melanoma cell death. These findings suggest that miR-26a may serve as a promising novel therapy for subsets of melanoma.

UR - http://www.scopus.com/inward/record.url?scp=84876557026&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84876557026&partnerID=8YFLogxK

U2 - 10.1038/jid.2012.505

DO - 10.1038/jid.2012.505

M3 - Article

C2 - 23594536

AN - SCOPUS:84876557026

VL - 133

SP - 1137

EP - 1139

JO - Journal of Investigative Dermatology

JF - Journal of Investigative Dermatology

SN - 0022-202X

IS - 5

ER -